Nucleoside derivative and use thereof
Abstract
A nucleoside derivative represented below, or a salt thereof.(In (1), R1 represents a hydrogen atom, a hydroxyl group or a protected group, and in (2), X represent a halogen atom. In (1) and (2), R2 and R4 each represent a hydrogen atom, a hydroxyl protecting, phosphate, or protected phosphate group, or —P(═O)nR5R6 (n is 0 or 1, R5 and R6 each representing a hydrogen atom, hydroxyl, protected hydroxyl, mercapto, protected mercapto, lower alkoxy, cyano lower alkoxy, amino or substituted amino group, when n is 1, R5 and R6 are not both hydrogen atoms), R3 represents NHR7 (R7 represents a hydrogen atom, alkyl, alkenyl or protecting group for an amino group), an azide, amidino or guanidino group, each having a linking group (when R7 is hydrogen atom, the linking group is an alkylene group), and B represents any of a purine-9-yl, 2-oxo-pyrimidin-1-yl, substituted purine-9-yl or substituted 2-oxo-pyrimidin-1-yl group.)
Claims
exact text as granted — not AI-modified1 . An oligonucleotide comprising a nucleoside derivative represented by formula (1) below, or a salt thereof:
wherein:
R 1 represents a hydrogen atom, a hydroxyl group, a hydroxyl group in which a hydrogen atom is substituted by an alkyl group or alkenyl group, or a protected group;
R 2 and R 4 may be the same or different, and each represents:
a hydrogen atom,
a hydroxyl protecting group,
a phosphate group,
a protected phosphate group, or
—P(═O) n R 5 R 6 , wherein:
n is 0 or 1, and
R 5 and R 6 may be the same or different, with each representing a hydrogen atom, hydroxyl group, protected hydroxyl group, mercapto group, protected mercapto group, lower alkoxy group, cyano lower alkoxy group, amino group or substituted amino group, but when n is 1, R 5 and R 6 are not both hydrogen atoms;
R 3 represents:
NHR 7 wherein R 7 represents a hydrogen atom, an alkyl group, an alkenyl group or a protecting group for an amino group,
an azide group,
an amidino group, or
a guanidino group,
each having a linking group, but when R 7 is hydrogen atom or a protecting group for an amino group, the linking group is an alkylene group which has 2 to 3 carbon atoms; and
B represents a nucleobase.
2 . The oligonucleotide according to claim 1 , wherein R 1 represents a protected group.
3 . The oligonucleotide according to claim 2 , wherein the protected group comprises fluorine.
4 . The oligonucleotide according to claim 2 , wherein the protected group comprises methyl.
5 . The oligonucleotide according to claim 1 , wherein said oligonucleotide is selected from the group consisting of a DNA molecule, a RNA molecule, and a duplex comprising a DNA and/or a RNA molecule.
6 . The oligonucleotide according to claim 1 , wherein said oligonucleotide comprises a nucleoside derivative represented by the structure:
wherein P is a protecting group comprising fluorine.
7 . The oligonucleotide according to claim 1 , wherein said oligonucleotide comprises a nucleoside derivative represented by the structure:
8 . An RNA molecule comprising a nucleoside derivative represented by formula (1) below, or a salt thereof:
wherein:
R 1 represents a hydrogen atom, a hydroxyl group, a hydroxyl group in which a hydrogen atom is substituted by an alkyl group or alkenyl group, or a protected group;
R 2 and R 4 may be the same or different, and each represents:
a hydrogen atom,
a hydroxyl protection group,
a phosphate group,
a protected phosphate group, or
—P(═O) n R 5 R 6 , wherein:
n is 0 or 1, and
R 5 and R 6 may be the same or different, with each representing a hydrogen atom, hydroxyl group, protected hydroxyl group, mercapto group, protected mercapto group, lower alkoxy group, cyano lower alkoxy group, amino group or substituted amino group, but when n is 1, R 5 and R 6 are not both hydrogen atoms;
R 3 represents:
NHR 7 , wherein R 7 represents a hydrogen atom, an alkyl group, an alkenyl group or a protecting group for an amino group,
an azide group,
an amidino group, or
a guanidino group,
each having a linking group, but when R 7 is hydrogen atom, the linking group is an alkylene group which has 2 to 3 carbon atoms; and
B represents any of a purine-9-yl group, 2-oxo-pyrimidin-1-yl group, substituted purine-9-yl group or substituted 2-oxo-pyrimidin-1-yl group; and
wherein said RNA molecule consists of an RNA interference agent.
9 . The RNA molecule according to claim 8 , wherein said RNA molecule consists of a siRNA.
10 . The RNA molecule according to claim 8 , wherein R 7 represents a hydrogen atom.
11 . The RNA molecule according to claim 8 , wherein R 1 represents a protected group.
12 . The RNA molecule according to claim 11 , wherein the protected group comprises fluorine.
13 . The RNA molecule according to claim 11 , wherein the protected group comprises methyl.
14 . The RNA molecule according to claim 8 , wherein the nucleoside derivative comprises the structure:
15 . The RNA molecule according to claim 8 , wherein the nucleoside derivative comprises the structure:
wherein P is a protecting group.
16 . The RNA molecule according to claim 15 , wherein P comprises fluorine.Join the waitlist — get patent alerts
Track US2023265120A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.